The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
The Human Antibody Response to Dengue Virus Infection
Open accessAbstract
Dengue viruses (DENV) are the causative agents of dengue fever (DF) and dengue hemorrhagic fever (DHF). Here we review the current state of knowledge about the human antibody response to dengue and identify important knowledge gaps. A large body of work has demonstrated that antibodies can neutralize or enhance DENV infection. Investigators have mainly used mouse monoclonal antibodies (MAbs) to study interactions between DENV and antibodies. These studies indicate that antibody neutralization of DENVs is a “multi-hit” phenomenon that requires the binding of multiple antibodies to neutralize a virion. The most potently neutralizing mouse MAbs bind to surface exposed epitopes on domain III of the dengue envelope (E) protein. One challenge facing the dengue field now is to extend these studies with mouse MAbs to better understand the human antibody response. The human antibody response is complex as it involves a polyclonal response to primary and secondary infections with 4 different DENV serotypes. Here we review studies conducted with immune sera and MAbs isolated from people exposed to dengue infections. Most dengue-specific antibodies in human immune sera are weakly neutralizing and bind to multiple DENV serotypes. The human antibodies that potently and type specifically neutralize DENV represent a small fraction of the total DENV-specific antibody response. Moreover, these neutralizing antibodies appear to bind to novel epitopes including complex, quaternary epitopes that are only preserved on the intact virion. These studies establish that human and mouse antibodies recognize distinct epitopes on the dengue virion. The leading theory proposed to explain the increased risk of severe disease in secondary cases is antibody dependent enhancement (ADE), which postulates that weakly neutralizing antibodies from the first infection bind to the second serotype and enhance infection of FcγR bearing myeloid cells such as monocytes and macrophages. Here we review results from human, animal and cell culture studies relevant to the ADE hypothesis. By understanding how human antibodies neutralize or enhance DENV, it will be possible to better evaluate existing vaccines and develop the next generation of novel vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kuhn, R. J., Zhang, W., Rossmann, M. G., Pletnev, S. V., Corver, J., Lenches, E., Jones, C. T., Mukhopadhyay, S., Chipman, P. R., Strauss, E. G., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00660-8 · Cited by 1,563
The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C., & Harrison, S. C. (1995) · Nature · doi:10.1038/375291a0 · Cited by 1,437
Mackenzie, J. S., Gubler, D. J., & Petersen, L. R. (2004) · Nature Medicine · doi:10.1038/nm1144 · Cited by 1,314
A structural perspective of the flavivirus life cycle
Mukhopadhyay, S., Kuhn, R. J., & Rossmann, M. G. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1067 · Cited by 1,292
Halstead, S. B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61687-0 · Cited by 1,287
A ligand-binding pocket in the dengue virus envelope glycoprotein
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832193100 · Cited by 1,061
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943
Neutralization and Antibody-Dependent Enhancement of Dengue Viruses
Halstead, S. B. (2003) · Advances in Virus Research · doi:10.1016/s0065-3527(03)60011-4 · Cited by 739
Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697
Beltramello, M., Williams, K. L., Simmons, C. P., Macagno, A., Simonelli, L., Quyen, N. T. H., Sukupolvi-Petty, S., Navarro-Sanchez, E., Young, P. R., de Silva, A. M., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.08.007 · Cited by 592
Self-citationKliks, S. C., Nimmanitya, S., Nisalak, A., & Burke, D. S. (1988) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1988.38.411 · Cited by 578
Kliks, S. C., Nisalak, A., Brandt, W. E., Wahl, L., & Burke, D. S. (1989) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1989.40.444 · Cited by 517
Conformational Changes of the Flavivirus E Glycoprotein
Zhang, Y., Zhang, W., Ogata, S. A., Clements, D. E., Strauss, J. H., Baker, T. S., Kuhn, R. J., & Rossmann, M. G. (2004) · Structure · doi:10.1016/j.str.2004.06.019 · Cited by 480
Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1223-1231.2005 · Cited by 429
Microevolution and virulence of dengue viruses
Rico-Hesse, R. (2003) · Advances in Virus Research · doi:10.1016/s0065-3527(03)59009-1 · Cited by 422
Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification
Balsitis, S. J., Williams, K. L., Lachica, R., Flores, D., Kyle, J. L., Mehlhop, E., Johnson, S., Diamond, M. S., Beatty, P. R., & Harris, E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000790 · Cited by 412
Halstead, S. B., Mahalingam, S., Marovich, M. A., Ubol, S., & Mosser, D. M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70166-3 · Cited by 409
Goncalvez, A. P., Engle, R. E., St. Claire, M., Purcell, R. H., & Lai, C.-J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703498104 · Cited by 364
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins
Lok, S.-M., Kostyuchenko, V., Nybakken, G. E., Holdaway, H. A., Battisti, A. J., Sukupolvi-Petty, S., Sedlak, D., Fremont, D. H., Chipman, P. R., Roehrig, J. T., et al. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1382 · Cited by 354
Endy, T. P., Nisalak, A., Chunsuttitwat, S., Vaughn, D. W., Green, S., Ennis, F. A., Rothman, A. L., & Libraty, D. H. (2004) · The Journal of Infectious Diseases · doi:10.1086/382280 · Cited by 340
Zellweger, R. M., Prestwood, T. R., & Shresta, S. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.01.004 · Cited by 338
Lai, C.-Y., Tsai, W.-Y., Lin, S.-R., Kao, C.-L., Hu, H.-P., King, C.-C., Wu, H.-C., Chang, G.-J., & Wang, W.-K. (2008) · Journal of Virology · doi:10.1128/jvi.00316-08 · Cited by 326
Original Antigenic Sin in Dengue
Halstead, S. B., Rojanasuphot, S., & Sangkawibha, N. (1983) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1983.32.154 · Cited by 289
Antigenic Structure of Flavivirus Proteins
Roehrig, J. T. (2003) · Advances in Virus Research · doi:10.1016/s0065-3527(03)59005-4 · Cited by 279
Wahala, W. M. P. B., Kraus, A. A., Haymore, L. B., Accavitti-Loper, M. A., & de Silva, A. M. (2009) · Virology · doi:10.1016/j.virol.2009.06.037 · Cited by 274
Self-citationImmature Dengue Virus: A Veiled Pathogen?
Rodenhuis-Zybert, I. A., van der Schaar, H. M., da Silva Voorham, J. M., van der Ende-Metselaar, H., Lei, H.-Y., Wilschut, J., & Smit, J. M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000718 · Cited by 268
Crystal Structure of the West Nile Virus Envelope Glycoprotein
Nybakken, G. E., Nelson, C. A., Chen, B. R., Diamond, M. S., & Fremont, D. H. (2006) · Journal of Virology · doi:10.1128/jvi.01125-06 · Cited by 264
Chareonsirisuthigul, T., Kalayanarooj, S., & Ubol, S. (2007) · Journal of General Virology · doi:10.1099/vir.0.82537-0 · Cited by 238
Crystal Structure of West Nile Virus Envelope Glycoprotein Reveals Viral Surface Epitopes
Kanai, R., Kar, K., Anthony, K., Gould, L. H., Ledizet, M., Fikrig, E., Marasco, W. A., Koski, R. A., & Modis, Y. (2006) · Journal of Virology · doi:10.1128/jvi.01735-06 · Cited by 235
In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
de Alwis, R., Beltramello, M., Messer, W. B., Sukupolvi-Petty, S., Wahala, W. M. P. B., Kraus, A., Olivarez, N. P., Pham, Q., Brian, J., Tsai, W.-Y., et al. (2011) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001188 · Cited by 216
Self-citationStructural basis for the preferential recognition of immature flaviviruses by a fusion‐loop antibody
Cherrier, M. V., Kaufmann, B., Nybakken, G. E., Lok, S., Warren, J. T., Chen, B. R., Nelson, C. A., Kostyuchenko, V. A., Holdaway, H. A., Chipman, P. R., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.245 · Cited by 213
Shrestha, B., Brien, J. D., Sukupolvi-Petty, S., Austin, S. K., Edeling, M. A., Kim, T., O'Brien, K. M., Nelson, C. A., Johnson, S., Fremont, D. H., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000823 · Cited by 208
An In-Depth Analysis of Original Antigenic Sin in Dengue Virus Infection
Midgley, C. M., Bajwa-Joseph, M., Vasanawathana, S., Limpitikul, W., Wills, B., Flanagan, A., Waiyaiya, E., Tran, H. B., Cowper, A. E., Chotiyarnwon, P., et al. (2011) · Journal of Virology · doi:10.1128/jvi.01826-10 · Cited by 200
Ubol, S., Phuklia, W., Kalayanarooj, S., & Modhiran, N. (2010) · The Journal of Infectious Diseases · doi:10.1086/651018 · Cited by 196
Chau, T. N. B., Quyen, N. T. H., Thuy, T. T., Tuan, N. M., Hoang, D. M., Dung, N. T. P., Lien, L. B., Quy, N. T., Hieu, N. T., Hieu, L. T. M., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/590117 · Cited by 186
Antibody-mediated neutralization of flaviviruses: A reductionist view
Dowd, K. A., & Pierson, T. C. (2011) · Virology · doi:10.1016/j.virol.2010.12.020 · Cited by 186
Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus
Oliphant, T., Nybakken, G. E., Austin, S. K., Xu, Q., Bramson, J., Loeb, M., Throsby, M., Fremont, D. H., Pierson, T. C., & Diamond, M. S. (2007) · Journal of Virology · doi:10.1128/jvi.00643-07 · Cited by 171
Libraty, D. H., Acosta, L. P., Tallo, V., Segubre-Mercado, E., Bautista, A., Potts, J. A., Jarman, R. G., Yoon, I.-K., Gibbons, R. V., Brion, J. D., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000171 · Cited by 171
Autoimmune Pathogenesis in Dengue Virus Infection
Lin, C.-F., Wan, S.-W., Cheng, H.-J., Lei, H.-Y., & Lin, Y.-S. (2006) · Viral Immunology · doi:10.1089/vim.2006.19.127 · Cited by 170
Mouse models of dengue virus infection and disease
YAUCH, L., & SHRESTA, S. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.06.010 · Cited by 169
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
Pierson, T. C., & Diamond, M. S. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000665 · Cited by 166
Blaney, J. E., Matro, J. M., Murphy, B. R., & Whitehead, S. S. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5516-5528.2005 · Cited by 162
How Innate Immune Mechanisms Contribute to Antibody-Enhanced Viral Infections
Ubol, S., & Halstead, S. B. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00316-10 · Cited by 151
Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection
Chan, K. R., Zhang, S. L.-X., Tan, H. C., Chan, Y., Chow, A. Y., Lim, A. P. C., Vasudevan, S. G., Hanson, B. J., & Ooi, E. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106568108 · Cited by 148
Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3
Brien, J. D., Austin, S. K., Sukupolvi-Petty, S., O’Brien, K. M., Johnson, S., Fremont, D. H., & Diamond, M. (2010) · Journal of Virology · doi:10.1128/jvi.01190-10 · Cited by 145
Mehlhop, E., Ansarah-Sobrinho, C., Johnson, S., Engle, M. J., Fremont, D. H., Pierson, T. C., & Diamond, M. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.09.015 · Cited by 141
Characterization of neutralizing antibodies to West Nile virus
Sánchez, M. D., Pierson, T. C., McAllister, D. J., Hanna, S. L., Puffer, B. A., Valentine, L. E., Murtadha, M., Hoxie, J. A., & Doms, R. W. (2005) · Virology · doi:10.1016/j.virol.2005.02.020 · Cited by 138
Vogt, M. R., Dowd, K. A., Engle, M. J., Tesh, R. B., Johnson, S., Pierson, T. C., & Diamond, M. (2011) · Journal of Virology · doi:10.1128/jvi.05859-11 · Cited by 134
Immunology and Immunopathogenesis of Dengue Disease
Rothman, A. L. (2003) · Advances in virus research · doi:10.1016/s0065-3527(03)60010-2 · Cited by 132
Boonnak, K., Dambach, K. M., Donofrio, G. C., Tassaneetrithep, B., & Marovich, M. (2010) · Journal of Virology · doi:10.1128/jvi.00220-10 · Cited by 131
West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody
Kaufmann, B., Nybakken, G. E., Chipman, P. R., Zhang, W., Diamond, M., Fremont, D. H., Kuhn, R. J., & Rossmann, M. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603488103 · Cited by 128
Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
Wahala, W. M. P. B., Donaldson, E., de Alwis, R., Accavitti-Loper, M. A., Baric, R. S., & de Silva, A. M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000821 · Cited by 128
Self-citationKaufmann, B., Vogt, M. R., Goudsmit, J., Holdaway, H. A., Aksyuk, A. A., Chipman, P. R., Kuhn, R. J., Diamond, M., & Rossmann, M. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011036107 · Cited by 128
Chau, T. N. B., Hieu, N. T., Anders, K. L., Wolbers, M., Lien, L. B., Hieu, L. T. M., Hien, T. T., Hùng, N. T., Farrar, J., Whitehead, S. S., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/648407 · Cited by 125
Koraka, P., Suharti, C., Setiati, T. E., Mairuhu, A., Gorp, E. V., Hack, C. E., Juffrie, M., Sutaryo, J., Meer, G. M. V. D., Groen, J., et al. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.12.4332-4338.2001 · Cited by 116
Mehlhop, E., Nelson, S., Jost, C. A., Gorlatov, S. N., Johnson, S., Fremont, D. H., Diamond, M., & Pierson, T. C. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.09.003 · Cited by 112
TRANSPLACENTALLY TRANSFERRED MATERNAL-INFANT ANTIBODIES TO DENGUE VIRUS
Watanaveeradej, V., Endy, T. P., Samakoses, R., Kerdpanich, A., Simasathien, S., Polprasert, N., Aree, C., Vaughn, D. W., HO, C., & Nisalak, A. (2003) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.69.123 · Cited by 105
Schieffelin, J. S., Costin, J. M., Nicholson, C. O., Orgeron, N. M., Fontaine, K. A., Isern, S., Michael, S. F., & Robinson, J. E. (2010) · Virology Journal · doi:10.1186/1743-422x-7-28 · Cited by 103
Vogt, M. R., Moesker, B., Goudsmit, J., Jongeneelen, M. A. C., Austin, S. K., Oliphant, T., Nelson, S., Pierson, T. C., Wilschut, J., Throsby, M., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00286-09 · Cited by 101
RNA virus genomics: a world of possibilities
Holmes, E. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38050 · Cited by 100
Antibody to Dengue 1 Detected More Than 60 Years after Infection
Imrie, A. A., Meeks, J., Gurary, A., Sukhbataar, M., Truong, T. T., Cropp, C. B., & Effler, P. V. (2007) · Viral Immunology · doi:10.1089/vim.2007.0050 · Cited by 99
Lai, C., Goncalvez, A. P., Men, R., Wernly, C., Donau, O. K., Engle, R. E., & Purcell, R. H. (2007) · Journal of Virology · doi:10.1128/jvi.01420-07 · Cited by 91
Kyle, J. L., Balsitis, S. J., Zhang, L. H., Beatty, P. R., & Harris, E. (2008) · Virology · doi:10.1016/j.virol.2008.08.008 · Cited by 76
Koraka, P., Murgue, B., Deparis, X., et al. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10358 · Cited by 75
Kou, Z., Lim, J. Y. H., Beltramello, M., Quinn, M., Chen, H., Liu, S.-N., Martínez‐Sobrido, L., Diamond, M., Schlesinger, J. J., de Silva, A., et al. (2010) · Virology · doi:10.1016/j.virol.2010.11.007 · Cited by 72
Fish, S., Zenowich, E., Fleming, M. D., & Manser, T. L. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.4.1191 · Cited by 70
Complement and its role in protection and pathogenesis of flavivirus infections
Avirutnan, P., Mehlhop, E., & Diamond, M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.061 · Cited by 66
Li, L., Barrett, A. D. T., & Beasley, D. W. C. (2005) · Virology · doi:10.1016/j.virol.2005.02.011 · Cited by 56
Probing the Flavivirus Membrane Fusion Mechanism by Using Monoclonal Antibodies
Stiasny, K., Brandler, S., Kössl, C., & Heinz, F. X. (2007) · Journal of Virology · doi:10.1128/jvi.01041-07 · Cited by 49
B Cell Lineage Contributions to Antiviral Host Responses
Baumgarth, N., Choi, Y. S., Rothaeusler, K., Yang, Y., & Herzenberg, L. A. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-73900-5_3 · Cited by 42
Human IgG Subclasses:In VitroNeutralization of andIn VivoProtection against West Nile Virus
Hofmeister, Y., Planitzer, C. B., Farcet, M. R., Teschner, W., Butterweck, H. A., Weber, A., Holzer, G. W., & Kreil, T. R. (2010) · Journal of Virology · doi:10.1128/jvi.02155-10 · Cited by 41
The neutralizing antibody response against West Nile virus in naturally infected horses
Sánchez, M. D., Pierson, T. C., DeGrace, M. M., Mattei, L. M., Hanna, S. L., Piero, F. D., & Doms, R. W. (2006) · Virology · doi:10.1016/j.virol.2006.08.047 · Cited by 39
dos Santos, F. B., Miagostovich, M. P., Nogueira, R. M. R., Schatzmayr, H. G., Riley, L. W., & Harris, E. (2004) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.144 · Cited by 25
Cited by
Sabchareon, A., Wallace, D., Sirivichayakul, C., Limkittikul, K., Chanthavanich, P., Suvannadabba, S., Jiwariyavej, V., Dulyachai, W., Pengsaa, K., Wartel, T. A., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61428-7 · Cited by 818
Guzman, M. G., Gubler, D. J., Izquierdo, A., Martinez, E., & Halstead, S. B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.55 · Cited by 762
Peptide Vaccine: Progress and Challenges
Li, W., Joshi, M., Singhania, S., Ramsey, K., & Murthy, A. (2014) · Vaccines · doi:10.3390/vaccines2030515 · Cited by 679
Dengue virus: epidemiology, biology, and disease aetiology
Roy, S. K., & Bhattacharjee, S. (2021) · Canadian Journal of Microbiology · doi:10.1139/cjm-2020-0572 · Cited by 440
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico
Robbiani, D. F., Bozzacco, L., Keeffe, J. R., Khouri, R., Olsen, P. C., Gazumyan, A., Schaefer-Babajew, D., Avila-Rios, S., Nogueira, L., Patel, R., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.024 · Cited by 333
Metadata
- Authors
- Wahala, W. M. P. B., & De Silva, A. M.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2011-11-25
- Volume
- 3
- Issue
- 12
- Pages
- 2374-2395
- ISSN
- 1999-4915 (ISSN-L)
- OpenAlex
- W2081356962
- Cited by
- 354
- References
- 73
- FWCI
- 17.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.